Viewing Study NCT01266135

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2026-03-13 @ 5:58 AM
Study NCT ID: NCT01266135
Status: TERMINATED
Last Update Posted: 2020-12-19
First Post: 2010-12-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Idiopathic Pulmonary Fibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Interstitial Lung Disease View
None Usual Interstitial Pneumonia View
None Fibrosis, View
None Pulmonary Fibrosis, View
None Respiratory Disease, View
None Interstitial Lung Disease, View
None Biological Therapy, View
None Therapeutic Uses, View